Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Humanwell Healthcare (Group) Co's EV-to-FCF or its related term are showing as below:
SHSE:600079'
s EV-to-FCF Range Over the Past 10 Years
Min: -332.9 Med: 30.88 Max: 5282.29
Current: 13.73
During the past 13 years, the highest EV-to-FCF of Humanwell Healthcare (Group) Co was 5282.29. The lowest was -332.90. And the median was 30.88.
SHSE:600079's EV-to-FCF is ranked better than 66.37% of 562
companies
in the Drug Manufacturers industry
Industry Median: 20.955
vs SHSE:600079: 13.73
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Humanwell Healthcare (Group) Co (SHSE:600079) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Humanwell Healthcare (Group) Co's PE Ratio (TTM) for today is calculated as:
Humanwell Healthcare (Group) Co's share price for today is ¥17.41.
Humanwell Healthcare (Group) Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.170.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Humanwell Healthcare (Group) Co EV-to-FCF Related Terms
Humanwell Healthcare (Group) Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Humanwell Healthcare (Group) Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Humanwell Healthcare (Group) Co EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Humanwell Healthcare (Group) Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Humanwell Healthcare (Group) Co's EV-to-FCF falls into.
Humanwell Healthcare (Group) Co's current Enterprise Value is ¥35,163 Mil.
Humanwell Healthcare (Group) Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2,560 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Humanwell Healthcare (Group) Co (SHSE:600079) has a EV-to-FCF of 13.73 as of Jul. 14, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Humanwell Healthcare (Group) Co and its competitors. This is 56% below median its historical median of 30.88. According to the industry distribution chart, Humanwell Healthcare (Group) Co ranks #189 out of 562 companies in the Drug Manufacturers industry, placing it in the top 33.6%.
Is Humanwell Healthcare (Group) Co's EV-to-FCF too high?
Humanwell Healthcare (Group) Co's current EV-to-FCF of 13.73 is 56% below median its 10-year median of 30.88. The Drug Manufacturers industry median EV-to-FCF is 20.96. Humanwell Healthcare (Group) Co's value of 13.73 is 34.5% below this industry median. Based on the distribution chart, Humanwell Healthcare (Group) Co ranks #189 out of 562 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Humanwell Healthcare (Group) Co has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Humanwell Healthcare (Group) Co's EV-to-FCF compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Humanwell Healthcare (Group) Co ranks #189 out of 562 companies for EV-to-FCF. This puts Humanwell Healthcare (Group) Co in the upper half of its industry. The industry median EV-to-FCF is 20.96. Humanwell Healthcare (Group) Co's value of 13.73 is 34.5% below this benchmark. While the company's 10-year median is 30.88 vs. the industry median of 20.96, Humanwell Healthcare (Group) Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.96, based on 562 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Humanwell Healthcare (Group) Co's current EV-to-FCF of 13.73 is 34.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Humanwell Healthcare (Group) Co and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Humanwell Healthcare (Group) Co's current EV-to-FCF is 13.73, which is 56% below median its own 10-year median of 30.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Humanwell Healthcare (Group) Co stock overvalued right now?
Based on GuruFocus' analysis, Humanwell Healthcare (Group) Co (SHSE:600079) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥21.63, compared to a current price of ¥17.41 — trading 19.5% below its estimated fair value. The current EV-to-FCF is 13.73, which is 56% below median its 10-year median of 30.88 and 34.5% below the Drug Manufacturers industry median of 20.96. Humanwell Healthcare (Group) Co's overall GF Score™ is 61/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Humanwell Healthcare (Group) Co (SHSE:600079), the current EV-to-FCF is 13.73 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Humanwell Healthcare (Group) Co (SHSE:600079) Overvalued in 2026?
Based on GuruFocus' analysis, Humanwell Healthcare (Group) Co stock appears to be undervalued.
The current stock price of ¥17.41 is trading 19.5% below its estimated GF Value™ of ¥21.63.
GuruFocus considers Humanwell Healthcare (Group) Co to be Modestly Undervalued.
Key valuation signals for SHSE:600079:
EV-to-FCF: 13.73 (56% below median its 10-year median of 30.88)
GF Value™: ¥21.63 vs. price of ¥17.41 (19.5% below fair value)
Industry Position: 34.5% below the Drug Manufacturers median (#189 of 562)
No single metric tells the full story. See the SHSE:600079 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Humanwell Healthcare (Group) Co Business Description
Humanwell Healthcare (Group) Co Ltd is a China-based integrated healthcare solution provider. It provides medicinal products including fertility-regulating drugs, Uyghur medicine, traditional Chinese medicine, medical devices, over-the-counter medicines, anti-infection drugs, herbal medicines, and biological products. The organization has a business presence in China and other international countries.
61GF Score
Get the complete analysis for SHSE:600079
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600079 has been successfully added to your 
